摘要
目的:研究Notch1在肾透明细胞癌(clear cell renal cell carcinoma,ccRCC)组织中的表达变化情况,并探讨其相关临床意义。方法:采用免疫组化、实时荧光定量PCR技术检测52例肾透明细胞癌、40例癌旁肾组织中Notch1蛋白和mRNA的表达。结果:肾透明细胞癌及癌旁组织中Notch1蛋白阳性表达率分别为80.8%(42/52)、30.0%(12/40)(P<0.05);Notch1蛋白表达与肾透明细胞癌的TNM分期、Fuhrman分级、远处转移有关(P<0.05);肾透明细胞癌及癌旁组织中Notch1 mRNA相对表达量分别为0.317±0.044、0.153±0.038(P<0.05)。结论:Notch1蛋白及mRNA在肾透明细胞癌组织中表达明显增高。但在肾透明细胞癌发生、发展过程中的作用仍有待探讨。
Objective:To explore mRNA expression and significance of Notchl in clear cell renal cell carcinoma (ccRCC). Methods: Immunohistochemistry,real - time fluorescent quantitative PCR technique were selected to de-tect Notchl proteins and mRNA in 52 cases of ccRCC,40 cases of renal tissue adjacent to carcinoma. Results: Notchl protein positive expression rate in the ccRCC and the tissue adjacent to carcinoma were 80. 8% (42/52 ) , 30. 0%(12/40) ( P 〈 0. 05 ) . Notchl protein expression was correlated with TNM stage, grade of Fuhrman and distant metas-tasis (P〈0.05). Notchl mRNA relative expression in ccRCC and the tissue adjacent to carcinoma were 0.317 ± 0. 044,0. 153 ± 0. 038 ( P 〈 0. 05 ). Conclusion: Notchl is highly expressed in the ccRCC. Notchl may play a vital role in the development of the ccRCC,either promoting or inhibiting the carcinogenesis process.
出处
《现代肿瘤医学》
CAS
2018年第5期725-727,共3页
Journal of Modern Oncology
基金
山东省医药卫生科技发展计划面上项目(编号:2016WS0233)